1/27/2010

The FDA approved Roxane Laboratories' morphine sulfate oral solution for opioid-tolerant patients with moderate to severe pain. The approval covers the doses of 100 milligrams per 5 milliliters and 20 milligrams per 1 milliliter.

Related Summaries